1.Hidron, AI, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infection Control and Hospital Epidemiology 2008; 29: 996–1011.
2.McDougal, LK, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. Journal of Clinical Microbiology 2003; 41: 5113–5120.
3.Seybold, U, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clinical Infectious Diseases 2006; 42: 647–656.
4.Maree, C, et al. Community-associated methicillin-resistant Staphylococcus aureus strains causing healthcare-associated infections. Emerging Infectious Diseases 2007; 13: 236–242.
5.Rodriguez-Bano, J, et al. Clinical and molecular epidemiology of community-acquired, healthcare-associated and nosocomial methicillin-resistant Staphylococcus aureus in Spain. Clinical Microbioliology and Infection 2009; 15: 1111–1118.
6.Gonzalez, BE, et al. Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infection Control and Hospital Epidemiology 2006; 27: 1051–1056.
7.Klevens, RM, et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerging Infectious Diseases 2006; 12: 1991–1993.
8.Stranden, AM, et al. Emergence of SCCmec type IV as the most common type of methicillin-resistant Staphylococcus aureus in a university hospital. Infection 2009; 37: 44–48.
9.Lina, G, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29: 1128–1132.
10.Okuma, K, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. Journal of Clinical Microbiology 2002; 40: 4289–4294.
11.Moran, GJ, et al. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerging Infectious Diseases 2005; 11: 928–930.
12.Voyich, JM, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? Journal of Infectious Diseases 2006; 194: 1761–1770.
13.Labandeira-Rey, M, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315: 1130–1133.
14.Davis, SL, et al. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology 2006; 27: 1025–1031.
15.Wang, JT, et al. Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains. Journal of Infection 2010; 61: 449–457.
16.Kreisel, KM, et al. USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections? Diagnostic Microbiology and Infectious Disease 2011; 70: 285–290.
17.Ganga, R, et al. Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center. Journal of Clinical Microbiology 2009; 47: 590–595.
18.Kempker, RR, et al. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia. Journal of Infection 2010; 61: 372–381.
19.Hota, B, et al. Predictors of clinical virulence in community-onset methicillin-resistant Staphylococcus aureus infections: the importance of USA300 and pneumonia. Clinical Infectious Diseases 2011; 53: 757–765.
20.Moore, CL, et al. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections. International Journal of Antimicrobial Agents 2009; 34: 148–155.
21.Klevens, RM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 2007; 298: 1763–1771.
22.Horan, TC, Andrus, M, Dudeck, MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control 2008; 36: 309–332.
23.Wenzel, RP. Perspective: attributable mortality – the promise of better antimicrobial therapy. Journal of Infectious Diseases 1998; 178: 917–919.
24.Miller, LG, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clinical Infectious Diseases 2007; 44: 471–482.
25.Miller, LG, et al. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clinical Infectious Diseases 2007; 44: 483–492.
26.Yang, ES, et al. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clinical Microbiology and Infection 2010; 16: 425–431.
27.Charlson, ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987; 40: 373–383.
28.Knaus, WA, et al. APACHE II: a severity of disease classification system. Critical Care Medicine 1985; 13: 818–829.
29.Mellmann, A, et al. Based upon repeat pattern (BURP): an algorithm to characterize the long-term evolution of Staphylococcus aureus populations based on spa polymorphisms. BMC Microbiology 2007; 7: 98.
30.Enright, MC, et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. Journal of Clinical Microbiology 2000; 38: 1008–1015.
31.Goering, RV, et al. Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. Journal of Clinical Microbiology 2008; 46: 2842–2847.
32.Brown, ML, et al. Prevalence and sequence variation of Panton-Valentine leukocidin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the United States. Journal of Clinical Microbiology 2012; 50: 86–90.
33.Kleinbaum, DG, Klein, M, Pryor, ER. Logistic Regression: a Self-learning Text. (Statistics for Biology and Health). Ebooks Corp., 2002.
34.Robinson, JO, et al. Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review. European Journal of Clinical Microbiology & Infectious Diseases 2009; 28: 353–361.
35.Lin, CC, et al. Methicillin-resistant Staphylococcus aureus bacteremia in patients with end-stage renal disease in Taiwan: distinguishing between community-associated and healthcare-associated strains. Infection Control and Hospital Epidemiology 2009; 30: 89–92.
36.Park, SH, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea. Infection Control and Hospital Epidemiology 2009; 30: 146–155.
37.Roberts, MC, et al. Characterization of methicillin-resistant Staphylococcus aureus isolated from public surfaces on a university campus, student homes and local community. Journal of Applied Microbiology 2011; 110: 1531–1537.
38.Diep, BA, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Annals of Internal Medicine 2008; 148: 249–257.
39.Han, LL, et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. Journal of Clinical Microbiology 2007; 45: 1350–1352.